Meda shareholders accept Mylan purchase offer
PITTSBURGH — Mylan on Tuesday announced that its offer to acquire Meda Aktiebolag for about $9.9 billion, has been accepted by 94% of Meda’s shareholders, collectively possessing 342,578,694 shares.
Mylan will go through with the deal, which it expects to close on or around Aug. 5, at which time Meda will become a controlled subsidiary of Mylan. The offer was initially announced on Feb. 10.
“Mylan is incredibly excited about this transaction and looks forward to welcoming Meda's leadership and talented employees to the Mylan organization upon closing,” Mylan said on its website about the deal. “Mylan has come to know Meda’s business, organization and culture extremely well through its EpiPen Auto-Injector partnership, and is confident the fit between the two companies is strong.”